CureVac N.V.

NASDAQ:CVAC

3.59 (USD) • At close May 8, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018
Revenue 535.1853.75867.42102.9948.917.41612.871
Cost of Revenue 105.829124.366183.993238.19514.17327.98317.744
Gross Profit 429.351-70.608-116.573-135.20534.727-10.567-4.873
Gross Profit Ratio 0.802-1.313-1.729-1.3130.71-0.607-0.379
Reseach & Development Expenses 153.034115.72462.55815.907113.80843.24241.722
General & Administrative Expenses 56.37576.00988.99487.20145.02942.18320.415
Selling & Marketing Expenses 4.4470.4240.4171.7430.7331.7551.085
SG&A 60.82276.43389.41188.94445.76243.93821.5
Other Expenses 37.81311.442-17.682-627.793-0.871.754.729
Operating Expenses 251.669203.599134.279277.058158.788.9367.951
Operating Income 177.682-274.207-249.457-412.263-124.002-99.498-72.824
Operating Income Ratio 0.332-5.101-3.7-4.003-2.536-5.713-5.658
Total Other Income Expenses Net 13.19914.2380.302-0.235-20.033-0.6271.693
Income Before Tax 190.881-259.969-249.155-412.498-129.8-100.125-71.131
Income Before Tax Ratio 0.357-4.836-3.696-4.005-2.654-5.749-5.526
Income Tax Expense 28.6950.198-0.126-0.782-0.726-0.2520.11
Net Income 162.186-260.167-249.029-411.716-129.074-99.873-71.241
Net Income Ratio 0.303-4.84-3.694-3.998-2.64-5.735-5.535
EPS 0.72-1.18-1.32-2.21-0.98-0.53-0.4
EPS Diluted 0.72-1.18-1.32-2.21-0.98-0.53-0.4
EBITDA 209.69-234.09-209.386-386.486-123.095-91.501-69.851
EBITDA Ratio 0.392-4.355-3.106-3.753-2.517-5.254-5.427